Ophthalmic Surgical Devices and Therapeutics Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

Ophthalmic Surgical Devices and Therapeutics Market: Key Segments

Based on product type, the global ophthalmic surgical devices and therapeutics market has been segmented into therapeutics, surgical devices, and vision care. In terms of end-user, the global ophthalmic surgical devices and therapeutics market has been divided into hospitals, ophthalmic clinics, and ambulatory surgery centers. Market size and forecast for each of these segments have been provided for the period 2018 to 2026, along with their respective CAGR for the forecast period 2016 to 2026, considering 2017 as the base year.

Ophthalmic Surgical Devices and Therapeutics Market: Regional Outlook

In terms of region, the global ophthalmic surgical devices and therapeutics market has been segmented into five major regions: North America (the U.S. and Canada), Europe (the U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (India, China, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (South Africa, GCC Countries, and Rest of Middle East & Africa). Market size and forecast for each of these regions and the mentioned countries have been provided for the period 2018 to 2026, along with their respective CAGR for the forecast period 2016 to 2026, considering 2017 as the base year. The research study also covers the competitive scenario in these regions.

Companies Mentioned in the Report

The report also profiles major players operating in the global ophthalmic surgical devices and therapeutics market based on various attributes, such as company overview, financial overview, product portfolio, business strategies, and recent developments. The players covered in the report include Allergan Plc., Johnson & Johnson Services, Inc., F. Hoffmann-La Roche Ltd., Novartis AG, Bausch Health Companies Inc., Regeneron Pharmaceuticals, Inc., Santen Pharmaceutical Co., Ltd., Carl Zeiss Meditec AG, HOYA Corporation, and Bayer AG. The global ophthalmic surgical devices and therapeutics market has been segmented as below:

Ophthalmic Surgical Devices and Therapeutics Market, by Product Type
Therapeutics
Anti-inflammatory Drugs
NSAIDs
Steroids
Anti-infective Drugs
Anti-fungal Drugs
Anti-bacterial Drugs
Others
Anti-infective Drugs
Alpha Agonist
Beta Blockers
Prostaglandin Analogs
Combined Medication
Others
Anti-allergy Drugs
Anti-VEGF Agents
Others
Surgical Devices
Cataract Surgery Devices
Intraocular lens (IOL)
Ophthalmic Viscoelastic Devices (OVDs)
Others
Glaucoma Surgery Devices
Refractive Surgery Devices
Vitreoretinal Surgery Devices
Vision Care
Contact Lenses
Spectacle Lenses
Accessories
Ophthalmic Surgical Devices and Therapeutics Market, by End-user
Hospitals
Ophthalmic Clinics
Ambulatory Surgery Centers
Ophthalmic Surgical Devices and Therapeutics Market, by Region
North America
U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Rest of Europe
Asia Pacific
India
China
Japan
Australia & New Zealand
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
South Africa
GCC Countries
Rest of Middle East & Africa

Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.